S447X variant of the lipoprotein lipase gene, lipids, and risk of coronary heart disease in 3 prospective cohort studies

American Heart Journal

Volumn 157, Issue 2, 2009, Pages 384-390

  Jensen, Majken K ^a,b,c   Rimm, Eric B ^a,d   Rader, Daniel ^e   Schmidt, Erik B ^c   Sørensen, Thorkild I A ^f   Vogel, Ulla ^g   Overvad, Kim ^b,c   Mukamal, Kenneth J ^h  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f The Capital Region   (Denmark)

^g National Research Centre for the Work Environment   (Denmark)

^h BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY RISK; DENMARK; FEMALE; FOLLOW UP; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; LPL GENE; MAJOR CLINICAL STUDY; MOLECULAR MECHANICS; NURSE; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; S447X GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSITY; ADULT; AGED; ALCOHOL DRINKING; CASE-CONTROL STUDIES; CORONARY DISEASE; FEMALE; GENOTYPE; HEALTH BEHAVIOR; HUMANS; LIPIDS; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 58949101076     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.10.008     Document Type: Article

References (47)

1. Nordestgaard B.G., Benn M., Schnohr P., et al. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298 (2007) 299-308
2. Gordon T., Castelli W.P., Hjortland M.C., et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62 (1977) 707-714
3. Preiss-Landl K., Zimmermann R., Hammerle G., et al. Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism. Curr Opin Lipidol 13 (2002) 471-481
4. Rip J., Nierman M.C., Wareham N.J., et al. Serum lipoprotein lipase concentration and risk for future coronary artery disease: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol 26 (2006) 637-642
5. Murthy V., Julien P., and Gagne C. Molecular pathobiology of the human lipoprotein lipase gene. Pharmacol Ther 70 (1996) 101-135
6. Rip J., Nierman M.C., Ross C.J., et al. Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation. Arterioscler Thromb Vasc Biol 26 (2006) 1236-1245
7. Ross C.J., Liu G., Kuivenhoven J.A., et al. Complete rescue of lipoprotein lipase-deficient mice by somatic gene transfer of the naturally occurring LPLS447X beneficial mutation. Arterioscler Thromb Vasc Biol 25 (2005) 2143-2150
8. Groenemeijer B.E., Hallman M.D., Reymer P.W., et al. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group. Circulation 95 (1997) 2628-2635
9. Wittrup H.H., Tybjaerg-Hansen A., Steffensen R., et al. Mutations in the lipoprotein lipase gene associated with ischemic heart disease in men. The Copenhagen City Heart Study. Arterioscler Thromb Vasc Biol 19 (1999) 1535-1540
10. Garenc C., Perusse L., Gagnon J., et al. Linkage and association studies of the lipoprotein lipase gene with postheparin plasma lipase activities, body fat, and plasma lipid and lipoprotein concentrations: the HERITAGE Family Study. Metabolism 49 (2000) 432-439
11. Huang A.Q., Hu Y.H., Zhan S.Y., et al. Lipoprotein lipase gene S447X polymorphism modulates the relation between central obesity and serum lipids, a twin study. Int J Obes (Lond) 30 (2006) 1693-1701
12. Gagne S.E., Larson M.G., Pimstone S.N., et al. A common truncation variant of lipoprotein lipase (Ser447X) confers protection against coronary heart disease: the Framingham Offspring Study. Clin Genet 55 (1999) 450-454
13. Jemaa R., Fumeron F., Poirier O., et al. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. Etude Cas Temoin sur l'Infarctus du Myocarde. J Lipid Res 36 (1995) 2141-2146
14. Sing K., Ballantyne C.M., Ferlic L., et al. Lipoprotein lipase gene mutations, plasma lipid levels, progression/regression of coronary atherosclerosis, response to therapy, and future clinical events. Lipoproteins and Coronary Atherosclerosis Study. Atherosclerosis 144 (1999) 435-442
15. Kathiresan S., Melander O., Guiducci C., et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40 (2008) 189-197
16. Wittrup H.H., Nordestgaard B.G., Steffensen R., et al. Effect of gender on phenotypic expression of the S447X mutation in LPL: the Copenhagen City Heart Study. Atherosclerosis 165 (2002) 119-126
17. Clee S.M., Loubser O., Collins J., et al. The LPL S447X cSNP is associated with decreased blood pressure and plasma triglycerides, and reduced risk of coronary artery disease. Clin Genet 60 (2001) 293-300
18. Arca M., Campagna F., Montali A., et al. The common mutations in the lipoprotein lipase gene in Italy: effects on plasma lipids and angiographically assessed coronary atherosclerosis. Clin Genet 58 (2000) 369-374
19. Brousseau M.E., Goldkamp A.L., Collins D., et al. Polymorphisms in the gene encoding lipoprotein lipase in men with low HDL-C and coronary heart disease: the Veterans Affairs HDL Intervention Trial. J Lipid Res 45 (2004) 1885-1891
20. Chen W., Srinivasan S.R., Elkasabany A., et al. Influence of lipoprotein lipase serine 447 stop polymorphism on tracking of triglycerides and HDL cholesterol from childhood to adulthood and familial risk of coronary artery disease: the Bogalusa Heart Study. Atherosclerosis 159 (2001) 367-373
21. Yang Y., Ruiz-Narvaez E., Niu T., et al. Genetic variants of the lipoprotein lipase gene and myocardial infarction in the Central Valley of Costa Rica. J Lipid Res 45 (2004) 2106-2109
22. Lee J., Tan C.S., Chia K.S., et al. The lipoprotein lipase S447X polymorphism and plasma lipids: interactions with APOE polymorphisms, smoking, and alcohol consumption. J Lipid Res 45 (2004) 1132-1139
23. Komurcu-Bayrak E., Onat A., Poda M., et al. The S447X variant of lipoprotein lipase gene is associated with metabolic syndrome and lipid levels among Turks. Clin Chim Acta 383 (2007) 110-115
24. Senti M., Bosch M., Aubo C., et al. Relationship of abdominal adiposity and dyslipemic status in women with a common mutation in the lipoprotein lipase gene. The REGICOR investigators. Atherosclerosis 150 (2000) 135-141
25. Vohl M.C., Lamarche B., Moorjani S., et al. The lipoprotein lipase HindIII polymorphism modulates plasma triglyceride levels in visceral obesity. Arterioscler Thromb Vasc Biol 15 (1995) 714-720
26. Humphries S.E., Nicaud V., Margalef J., et al. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS). Arterioscler Thromb Vasc Biol 18 (1998) 526-534
27. Colditz G.A., Manson J.E., and Hankinson S.E. The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health 6 (1997) 49-62
28. Rimm E.B., Giovannucci E.L., Stampfer M.J., et al. Reproducibility and validity of a expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 135 (1992) 1114-1126
29. Tjonneland A., Olsen A., Boll K., et al. Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 35 (2007) 432-441
30. Rimm E.B., Giovannucci E.L., Willett W.C., et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 338 (1991) 464-468
31. Prentice R.L., and Breslow N.E. Retrospective studies and failure time models. Biometrika 65 (1978) 153-158
32. Joensen AM, Jensen MK, Overvad K, et al. Predictive Value of Acute Coronary Syndrome Discharge Diagnoses in the Danish National Patient Registry. J Clin Epidemiol (Electronic Publication 2008 August 20).
33. Pai J.K., Curhan G.C., Cannuscio C.C., et al. Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection. Clin Chem 48 (2002) 1781-1784
34. Prentice R.L. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 73 (1986) 1-12
35. Petersen L., Sorensen T.I., and Andersen P.K. Comparison of case-cohort estimators based on data on premature death of adult adoptees. Stat Med 22 (2003) 3795-3803
36. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 7 (1986) 177-188
37. Samani N.J., Erdmann J., Hall A.S., et al. Genomewide association analysis of coronary artery disease. N Engl J Med 357 (2007) 443-453
38. Superko H.R., and King III S. Lipid management to reduce cardiovascular risk: a new strategy is required. Circulation 117 (2008) 560-568
39. Nissen S.E., Tardif J.C., Nicholls S.J., et al. Effect of torcetrapib on the progression of coronary atherosclerosis. N Engl J Med. 356 (2007) 1304-1316
40. Barter P.J., Caulfield M., Eriksson M., et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 357 (2007) 2109-2122
41. Tsutsumi K. Lipoprotein lipase and atherosclerosis. Curr Vasc Pharmacol 1 (2003) 11-17
42. Rip J., Nierman M.C., Sierts J.A., et al. Gene therapy for lipoprotein lipase deficiency: working toward clinical application. Hum Gene Ther 16 (2005) 1276-1286
43. Borggreve S.E., Hillege H.L., Wolffenbuttel B.H., et al. An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study. J Clin Endocrinol Metab 91 (2006) 3382-3388
44. Boekholdt S.M., Sacks F.M., Jukema J.W., et al. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation 111 (2005) 278-287
45. Keavney B., Palmer A., Parish S., et al. Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: discrepancies between genotype, blood lipid concentrations, and coronary disease risk. Int J Epidemiol 33 (2004) 1002-1013
46. Merkel M., Kako Y., Radner H., et al. Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases very low density lipoprotein uptake: direct evidence that lipoprotein lipase bridging occurs in vivo. Proc Natl Acad Sci U S A 95 (1998) 13841-13846
47. Clee S.M., Bissada N., Miao F., et al. Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis. J Lipid Res 41 (2000) 521-531